Ixazomib Citrate
- Generic Name: Ixazomib Citrate
- Strength: 4 mg, 3 mg, and 2.3 mg Capsules.
Ixazomib Citrate acts as the proteasome inhibitor.
- Ixazomib is recommended together with the dexamethasone and lenalidomide for treating multiple myeloma.
- It increased the median time of progression-free survival from 14.7 months to 20.6 months.
- Ixazomib is a peptide analogue and boronic acid.
- It was developed by Takeda.
- In September 2015, the US FDA granted the approval of ixazomib together with lenalidomide and dexamethasone for multiple myeloma.
Ixazomib Uses: Ixazomib belongs to a proteasome inhibitor class drug used in combination with dexamethasone and lenalidomide for the treatment of multiple myeloma patients who have at least received one prior therapy.
It is available in capsule form of concentrations 2.3mg, 3mg, and 4mg.
What is multiple myeloma?
Abnormal growth of Plasma cell which is a type of white blood cell causes multiple myeloma. These normal plasma cells are used to produce antibodies that fight against infections and germs.
Multiple myeloma results in the accumulation of cancerous cells in the bone marrow that produces abnormal proteins leading to a complication of an unusual antibody.
How long can a person live with multiple myeloma?
Overall the five year survival rate is approx 54 percent. With the help of high-dose therapy followed by the ASCT, the estimated median survival is about 4.5 years, compared to the median approx 3.5 years with the standard therapy.
Multiple myeloma signs and symptoms: The signs and symptoms of multiple myeloma range from mild to severe. The symptoms are:
- Excessive thirst
- Weakness
- Frequent infection
- Numbness in your legs
- Weight loss
- Loss of appetite
- Nausea
- Constipation
- Confusion
- Bone pain
Multiple Myeloma Treatment: The major goal for the treatment of multiple myeloma is to help you live as long and as comfortably as possible. Multiple Myeloma is not like other cancers. It may be controlled and managed with the treatment for some time, but it could likely return. Targeted therapy, Biological therapy, Chemotherapy, Corticosteroids and Bone marrow transplant are the available treatment options for treating multiple myeloma.
List of multiple myeloma drugs: Apart from Ixazomib, there are several other medications which can be used for the treatment of multiple myeloma. These medications are mentioned below:List of multiple myeloma drugs: Apart from Ixazomib, there are several other medications which can be used for the treatment of multiple myeloma. These medications are mentioned below:
- Revlimid (lenalidomide)
- Baycadron (dexamethasone)
- Velcade (bortezomib)
- Thalomid (thalidomide)
- Kyprolis (carfilzomib)
- Darzalex (daratumumab)
- Adriamycin (doxorubicin)
- Empliciti (elotuzumab)
- Farydak (panobinostat)
- Pomalyst (pomalidomide)
- Cytoxan (cyclophosphamide)
- Pomalyst (pomalidomide)
- Alkeran (Melphalan)
- Mozobil (plerixafor)
- BiCNU (carmustine)
- Mozobil (plerixafor)
How does Ixazomib Citrate works: This drug works on both cancerous cells as well as healthy cells. These are the insane complexes that break unwanted and damaged proteins into smaller parts. These smaller parts are now used to produce normal proteins by the cell. Proteasome generally means recycling of protein.
Ixazomib side effects: A common side effect of this drug include: Ixazomib side effects: A common side effect of this drug include:
- Back pain
- Constipation
- Diarrhea
- Nausea
- Vomiting
- Peripheral edema
- Thrombocytopenia
- Peripheral neuropathy
- Severe adverse reaction of Ixazomib which when appear the patient should immediately consult to Healthcare professionals are:
- Gastrointestinal toxicity
- Hepatotoxicity
- Cutaneous region toxicity
- Embryo-fetal damage
- Rash
- Eye disorder
What is the dosage and form of Ixazomib Citrate is available?
Ixazomib Citrate is available as 4 mg, 3 mg, and 2.3 mg Capsules.
Urgent Meds is able to source Ixazomib Citrate® (Cancer Treatment Medicines) from across the globe and has the ability to supply. Urgent Meds offers its customers worldwide access to the best available treatment.
Urgent Meds is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the patient’s address only from New Delhi, India.
What are the indications and usage of Ixazomib?
Ixazomib is indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy.
How order will be confirmed?
The order will be confirmed only after the receipt of:
- Valid prescription of Oncologist
- Import permit if applicable
Is Ixazomib Citrate available in India?
Ixazomib is a prescription drug that legally requires a medical prescription to be dispensed.
Urgent Meds facilitates import of cancer medicines on the named patient supply. Urgent Meds provides input on:
- Availability in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.)
- Medicine Price
- Finding genuine and reliable sources from Canada, Europe, USA, and Australia
- Ensuring 100% transparency
Ixazomib Citrate can be made available in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, and other cities in India.
Urgent Meds can facilitate the supply of Ixazomib Citrate (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable).
Please contact toll-free at +91-1800-889-1064 or +1-647-818-4196 for Ixazomib price in India. Visit our website at urgentmeds.in.
Conclusion: Ixazomib is the most effective proteasome inhibitor class drug that breaks down abnormal proteins into smaller components. These smaller components can be reused in the cell for the production of normal proteins.
We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.